Private Advisor Group, LLC Athersys, Inc Transaction History

Private Advisor Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$0.18 - $0.86 $2,007 - $9,592	11,154 Added 24.89%	55,967 $14,000
Q1 2022 May 12, 2022	BUY	$0.6 - $1.06 $26,887 - $47,501	44,813 New	44,813 $27,000
Q4 2021 Feb 10, 2022	SELL	$0.85 - $1.4 $25,381 - $41,804	-29,860 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$1.33 - $1.77 $39,713 - $52,852	29,860 New	29,860 $41,000
Q2 2021 Aug 12, 2021	SELL	$1.41 - $1.94 $40,523 - $55,755	-28,740 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$1.61 - $2.77 $10,394 - $17,883	6,456 Added 28.97%	28,740 $52,000
Q4 2020 Apr 01, 2021	BUY	$1.55 - $2.24 $11,138 - $16,096	7,186 Added 47.6%	22,284 $39,000
Q3 2020 Nov 02, 2020	SELL	$1.91 - $3.08 $6,035 - $9,732	-3,160 Reduced 17.31%	15,098 $41,000
Q2 2020 Aug 17, 2020	SELL	$1.97 - $3.98 $1,172 - $2,368	-595 Reduced 3.16%	18,258 $51,000
Q3 2018 Nov 01, 2018	SELL	$1.86 - $2.18 $34,013 - $39,865	-18,287 Reduced 49.24%	18,853 $40,000
Q2 2018 Aug 09, 2018	BUY	$1.76 - $2.79 $32,185 - $51,020	18,287 Added 97.0%	37,140 $73,000
Q4 2017 Feb 07, 2018	SELL	$1.65 - $2.45 $1,650 - $2,450	-1,000 Reduced 5.04%	18,853 $34,000
Q2 2017 Aug 10, 2017	BUY	N/A	19,853	19,853 $30,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.